Brief: FDA Says Aware That Baxter Issued Letter To Affected Customers Recommending Certain Spectrum Infusion Pumps Be Removed From Where They Are Used Or Sold
July 1 (Reuters) - Baxter International Inc BAX.N: FDA: AWARE THAT BAXTER ISSUED LETTER TO AFFECTED CUSTOMERS RECOMMENDING CERTAIN SPECTRUM INFUSION PUMPS BE REMOVED FROM WHERE THEY ARE USED OR SOLD FDA: AS OF JUNE 12, BAXTER REPORTED NO SERIOUS INJURIES OR DEATHS ASSOCIATED WITH CERTAIN SPECTRUM INFUSION PUMPS ISSUE Further company coverage: BAX.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baxter International
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Press Digest: British Business - August 20
Brief: Baxter Appoints John Rogers Chief Financial Officer
Brief: Baxter Announces Pricing For Its Upsized Cash Tender Offers